ArticleCureus2024
Assessment of Public Knowledge and Awareness of Knee Osteoarthritis Among Individuals Aged 18-65 in the United Arab Emirates (UAE).
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
- Public insight into knee osteoarthritis: a cross-sectional study from the West Bank, Palestine.BMC public health · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Osteoarthritis (OA) is a disease characterized by chronic degeneration of articular cartilage and subchondral bone and inflammation of the synovium, leading to pain and joint disability. The best-known risk factors for OA are increasing age and obesity. Public knowledge of this disease should be assessed as OA, given its high prevalence, which places a significant burden on patients' daily activities and their overall quality of life. Methodology This cross-sectional study was conducted between September and November 2023 among the United Arab Emirates (UAE) population using an online survey form. The survey responses were then analyzed using the SPSS Statistics system (IBM Corp. IBM SPSS Statistics for Windows. Armonk, NY: IBM Corp). Results A total of 363 people participated in this study. The sample showed a high level of knowledge of the underlying mechanism of OA, with 233 (64.2%) correctly identifying the cause. In addition, most of the participants, 244 (67.2%), were aware that OA is a chronic disease, and 243 (66.9%) knew that it is not a rare disease. Moreover, 288 (79.6%) could identify that a high BMI is a major risk factor for OA. Total and partial joint replacement for advanced disease remain the mainstay of treatment. In this study, 241 (66.4%) participants knew that joint replacement surgery was the final option to relieve the symptoms of OA. The total knowledge level of the participants showed that only 74 (20.4%) had good knowledge, 91 (25.1%) had average knowledge, and a majority of 198 (54.5%) had poor knowledge. Our study showed that a higher level of education leads to a better understanding and awareness of OA, which is generally expected (p=0.019). In addition, trust in healthcare and study material as a source of information on the topic significantly impacts knowledge, in contrast to trust in relying on family, media, and personal history (p<0.001). Conclusion OA severely limits daily activities, and the prevalence of OA is anticipated to double in the next decade. In this study, we aimed to determine the level of public knowledge about knee OA. The results indicate that the level of knowledge among individuals aged 18 to 65 in the UAE is low. Accordingly, raising awareness among the public will result in early detection of the disease, clearing misconceptions, and controlling dangerous and unproven procedures for the treatment of OA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.